Randeep Kashyap

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. ncbi request reprint Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases--an analysis of the UNOS database
    Randeep Kashyap
    Department of Surgery, Division of Solid Organ Transplantation, University of Rochester Medical Center, P O Box SURG, 601 Elmwood Avenue, Rochester, NY 14642, USA
    J Gastrointest Surg 14:1362-9. 2010
  2. ncbi request reprint Stratifying risk of biliary complications in adult living donor liver transplantation by magnetic resonance cholangiography
    Randeep Kashyap
    Division of Transplantation, Department of Surgery, University of Rochester Medical Center, Rochester, NY 14642 8410, USA
    Transplantation 85:1569-72. 2008
  3. doi request reprint Comparative analysis of outcomes in living and deceased donor liver transplants for primary sclerosing cholangitis
    Randeep Kashyap
    Department of Surgery, Division of Solid Organ Transplantation, University of Rochester Medical Center, Box SURG, 601 Elmwood Avenue, Rochester, NY 14642, USA
    J Gastrointest Surg 13:1480-6. 2009
  4. doi request reprint Liver grafts from donors with central nervous system tumors: a single-center perspective
    Randeep Kashyap
    Division of Solid Organ Transplantation, Department of Surgery, University of Rochester Medical Center, Rochester, NY 14642, USA
    Liver Transpl 15:1204-8. 2009
  5. ncbi request reprint Pharmacokinetics of mycophenolic acid in live donor liver transplant patients vs deceased donor liver transplant patients
    Ashok Jain
    University of Rochester Medical Center, Department of Surgery, Division of Solid Organ Transplantation, Rochester, NY 14642, USA
    J Clin Pharmacol 48:547-52. 2008
  6. doi request reprint Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients
    Ashok Jain
    Department of Surgery, Division of Solid Organ Transplant, University of Rochester Medical Center, Rochester, NY, USA
    Transplantation 85:554-60. 2008
  7. doi request reprint Potential immunological advantage of intravenous mycophenolate mofetil with tacrolimus and steroids in primary deceased donor liver transplantation and live donor liver transplantation without antibody induction
    Ashokkumar Jain
    Department of Surgery, Division of Solid Organ Transplantation, University of Rochester Medical Center, Rochester, NY 14642, USA
    Liver Transpl 14:202-9. 2008
  8. doi request reprint Surgical complications following liver transplantation in patients with portal vein thrombosis--a single-center perspective
    Rajeev Sharma
    Division of Solid Organ Transplantation, Department of Surgery, University of Rochester Medical Center, Box SURG, Rochester, NY 14620, USA
    J Gastrointest Surg 14:520-7. 2010
  9. doi request reprint Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up
    Ashokkumar Jain
    Division of Abdominal Organ Transplantation, Department of Surgery, Temple University Hospital, Philadelphia, PA 19140, USA
    Transplantation 92:453-60. 2011
  10. doi request reprint Response to antiviral therapy in liver transplant recipients with recurrent hepatitis C viral infection: a single center experience
    Ashok Jain
    Department of Surgery, Division of Solid Organ Transplantation, University of Rochester Medical Center, Rochester, NY, USA
    Clin Transplant 24:104-11. 2010

Collaborators

Detail Information

Publications33

  1. ncbi request reprint Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases--an analysis of the UNOS database
    Randeep Kashyap
    Department of Surgery, Division of Solid Organ Transplantation, University of Rochester Medical Center, P O Box SURG, 601 Elmwood Avenue, Rochester, NY 14642, USA
    J Gastrointest Surg 14:1362-9. 2010
    ..However, there are only few reports comparing outcomes of both living donor liver transplants (LDLT) and deceased donor liver transplants (DDLT) for these conditions...
  2. ncbi request reprint Stratifying risk of biliary complications in adult living donor liver transplantation by magnetic resonance cholangiography
    Randeep Kashyap
    Division of Transplantation, Department of Surgery, University of Rochester Medical Center, Rochester, NY 14642 8410, USA
    Transplantation 85:1569-72. 2008
    ..Accurate preoperative assessment of biliary anatomy in live donor hepatectomy may be helpful to assess the suitability of a graft and to stratify risk of biliary complications...
  3. doi request reprint Comparative analysis of outcomes in living and deceased donor liver transplants for primary sclerosing cholangitis
    Randeep Kashyap
    Department of Surgery, Division of Solid Organ Transplantation, University of Rochester Medical Center, Box SURG, 601 Elmwood Avenue, Rochester, NY 14642, USA
    J Gastrointest Surg 13:1480-6. 2009
    ..We present a single-center experience on survival outcomes and disease recurrence for LDLT and DDLT for ESLD secondary to PSC...
  4. doi request reprint Liver grafts from donors with central nervous system tumors: a single-center perspective
    Randeep Kashyap
    Division of Solid Organ Transplantation, Department of Surgery, University of Rochester Medical Center, Rochester, NY 14642, USA
    Liver Transpl 15:1204-8. 2009
    ....
  5. ncbi request reprint Pharmacokinetics of mycophenolic acid in live donor liver transplant patients vs deceased donor liver transplant patients
    Ashok Jain
    University of Rochester Medical Center, Department of Surgery, Division of Solid Organ Transplantation, Rochester, NY 14642, USA
    J Clin Pharmacol 48:547-52. 2008
    ..These observations point to the need to use a lower dosage (approximately 30%) of mycophenolate mofetil in live donor liver transplant patients compared with deceased donor liver transplant patients...
  6. doi request reprint Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients
    Ashok Jain
    Department of Surgery, Division of Solid Organ Transplant, University of Rochester Medical Center, Rochester, NY, USA
    Transplantation 85:554-60. 2008
    ..AIM.: The aim of the present study is to compare the dosage, concentration and pharmacokinetics parameters of tacrolimus between LDLT and deceased donor liver transplant (DDLT) recipients...
  7. doi request reprint Potential immunological advantage of intravenous mycophenolate mofetil with tacrolimus and steroids in primary deceased donor liver transplantation and live donor liver transplantation without antibody induction
    Ashokkumar Jain
    Department of Surgery, Division of Solid Organ Transplantation, University of Rochester Medical Center, Rochester, NY 14642, USA
    Liver Transpl 14:202-9. 2008
    ..All patients responded to steroid therapy. None of the patients required any antibody preparation. In conclusion, IV MMF with tacrolimus and steroids is useful and required antirejection therapy in 6.1% of liver transplant recipients...
  8. doi request reprint Surgical complications following liver transplantation in patients with portal vein thrombosis--a single-center perspective
    Rajeev Sharma
    Division of Solid Organ Transplantation, Department of Surgery, University of Rochester Medical Center, Box SURG, Rochester, NY 14620, USA
    J Gastrointest Surg 14:520-7. 2010
    ..Portal vein thrombosis (PVT) was once considered a contraindication for liver transplantation (LTx) because of technical difficulties. Though no longer a contraindication, it remains a risk factor...
  9. doi request reprint Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up
    Ashokkumar Jain
    Division of Abdominal Organ Transplantation, Department of Surgery, Temple University Hospital, Philadelphia, PA 19140, USA
    Transplantation 92:453-60. 2011
    ..Hepatitis C virus (HCV) recurrence is universal after liver transplantation (LT). Whether the progression of recurrent HCV is faster after live-donor LT (LDLT) compared with deceased-donor LT (DDLT) is debatable...
  10. doi request reprint Response to antiviral therapy in liver transplant recipients with recurrent hepatitis C viral infection: a single center experience
    Ashok Jain
    Department of Surgery, Division of Solid Organ Transplantation, University of Rochester Medical Center, Rochester, NY, USA
    Clin Transplant 24:104-11. 2010
    ..Recurrence of hepatitis C virus (HCV) in hepatic allograft is a major concern after successful liver transplant (LTx)...
  11. ncbi request reprint Pharmacokinetics of mycophenolic acid in liver transplant patients after intravenous and oral administration of mycophenolate mofetil
    Ashok Jain
    Department of Surgery, Division of Transplantation, University of Rochester Medical Center, Rochester, NY 14642, USA
    Liver Transpl 13:791-6. 2007
    ..In conclusion, during the early postoperative period, LTx recipients have MPA exposure with oral MMF of less than half that of IV MMF. Use of IV MMF immediately post-LTx may provide an immunological advantage...
  12. doi request reprint High mortality in orthotopic liver transplant recipients who require hemodialysis
    Martin S Zand
    Division of Nephrology, University of Rochester Medical Center, Rochester, NY 14642, USA
    Clin Transplant 25:213-21. 2011
    ..5, and male gender. We conclude that renal failure requiring hemodialysis post liver transplant, irrespective of pre-transplant dialysis status, is a profound risk factor for death in liver transplant recipients...
  13. ncbi request reprint Intravenous mycophenolate mofetil with low-dose oral tacrolimus and steroid induction for live donor liver transplantation
    Ashok Jain
    Department of Surgery, Division of Transplantation, University of Rochester Medical Center, Box SURG, Rochester, NY 14642, USA
    Exp Clin Transplant 3:361-5. 2005
    ..Previously published studies have used oral formulations of MMF. In this study, we sought to examine survival, rejection, and nephrotoxicity rates using IV MMF in live donor liver transplantation (LDLT)...
  14. ncbi request reprint Incidence of abdominal wall numbness post-liver transplantation and its complications
    Ashokkumar Jain
    Division of Abdominal Organ Transplant, Department of Surgery, Temple University Hospital, Philadelphia, PA 19140, USA
    Liver Transpl 15:1488-92. 2009
    ..More then 24% of the patients used the area for subcutaneous injections of insulin and/or interferon...
  15. ncbi request reprint Postoperative impact of intraoperative biochemical changes at the completion of parenchymal division in living-donor liver transplantation
    Ashok Jain
    Department of Surgery, Division of Transplantation, University of Rochester Medical Center, Rochester, New York 14642, USA
    Exp Clin Transplant 4:544-8. 2006
    ....
  16. doi request reprint Recurrent nonhepatic and de novo malignancies after liver transplantation
    Ashokkumar Jain
    Department of Surgery, University of Rochester Medical Center, Rochester, NY, USA
    Transplantation 88:706-10. 2009
    ..However, the data for patients with a prior history of nonhepatic malignancy and its recurrence post-LTx are limited...
  17. pmc Diabetes mellitus impacts risk of macrovascular invasion in patients undergoing transplantation for hepatocellular carcinoma
    Gregory C Connolly
    The Department of Medicine, James P, Wilmot Cancer Center, and, University of Rochester, Rochester, NY, USA
    BMC Gastroenterol 13:9. 2013
    ..Diabetes mellitus (DM) is identified as a negative prognostic indicator in hepatocellular carcinoma (HCC), though the basis for this is unknown...
  18. doi request reprint Minimizing morbidity of organ donation: analysis of factors for perioperative complications after living-donor nephrectomy in the United States
    Siddharth Patel
    Division of Transplantation, Department of Surgery, University of Rochester Medical Center, Rochester, NY, USA
    Transplantation 85:561-5. 2008
    ..Wide variability exists in reported donor complications, and associated risk factors are ill defined. Use of administrative data can overcome the bias of single-center studies and identify variables associated with untoward events...
  19. ncbi request reprint Polysubstance abuse in liver transplant patients and its impact on survival outcome
    Mark Nickels
    Department of Psychiatry, University of Rochester Medical Center, Rochester, NY, USA
    Exp Clin Transplant 5:680-5. 2007
    ..It is important to understand posttransplant survival outcomes in patients with multiple substance abuse and pretransplant factors that predict relapse...
  20. ncbi request reprint Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis
    Adel Bozorgzadeh
    Department of Surgery, University of Rochester Medical Center, Rochester, NY, USA
    Liver Transpl 13:807-13. 2007
    ..Our results suggest that Milan selection criteria may be too limiting and lose their predictive power when applied to patients without HCV infection...
  21. ncbi request reprint University of Wisconsin versus histidine-tryptophan-ketoglutarate for tissue preservation in live-donor liver transplantation
    Ashok Jain
    Department of Surgery, Division of Transplantation, University of Rochester Medical Center, Rochester, NY 14642, USA
    Exp Clin Transplant 4:451-7. 2006
    ..We therefore sought to examine the hepatic function of live-donor liver transplantation allografts preserved in University of Wisconsin solution as compared with those preserved in histidine-tryptophan- ketoglutarate solution...
  22. ncbi request reprint Effect of liver transplant on pulmonary functions in adult patients with alpha 1 antitrypsin deficiency: 7 cases
    Ashokkumar B Jain
    Department of Surgery, Division of Abdominal Organ Transplant, Temple University Hospital, Philadelphia, PA 19140, USA
    Exp Clin Transplant 8:4-8. 2010
    ..The purpose of this study was to observe the changes in the pulmonary functions of patients who underwent liver transplant for the treatment of A1A deficiency...
  23. ncbi request reprint Pediatric liver and kidney transplantation with allografts from DCD donors: A review of UNOS data
    Peter Abt
    Department of Surgery, Solid Organ Transplantation and Hepatobiliary Surgery Division, University of Rochester Medical Center, Rochester, NY 14642 8410, USA
    Transplantation 82:1708-11. 2006
    ..While there is increasing acceptance of these grafts in adults, transplant centers appear reluctant to use these grafts in the pediatric population...
  24. ncbi request reprint The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis
    Ashok Jain
    Thomas E Starzl Transplantation Institute, Department of Surgery, Children s Hospital of Pittsburgh, 3705 Fifth Avenue, Pittsburgh, PA 15213, USA
    Transplantation 75:1020-5. 2003
    ..The purpose of this longitudinal study was to examine the incidence of biopsy-proven chronic rejection in long-term survivors of primary pediatric liver transplantation under tacrolimus-based immunosuppression...
  25. pmc Pediatric liver transplantation. A single center experience spanning 20 years
    Ashok Jain
    Department of Surgery, Thomas E Starzl Transplantation Institute, Children s Hospital of Pittsburgh, Pennsylvania 15213, USA
    Transplantation 73:941-7. 2002
    ....
  26. ncbi request reprint Modification of a biventricular assist device to facilitate preservative infusion and organ recovery in a nonheart-beating donor
    Ron Angona
    Department of Surgery, Division of Cardiothoracic Surgery, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA
    J Extra Corpor Technol 38:157-60. 2006
    ..This report discusses the technical aspects of this potentially beneficial procedure...
  27. doi request reprint Stereotactic hypofractionated radiation therapy as a bridge to transplantation for hepatocellular carcinoma: clinical outcome and pathologic correlation
    Alan W Katz
    Department of Radiation Oncology, University of Rochester Medical Center, Rochester, NY 14642, USA
    Int J Radiat Oncol Biol Phys 83:895-900. 2012
    ..We also examined histological response to radiation in the resected or explanted livers...
  28. ncbi request reprint Cryptosporidiasis in live related renal transplant recipients: a single center experience
    Mukut Minz
    Transplantation 77:1916-7. 2004
  29. ncbi request reprint Ribavirin dose modification based on renal function is necessary to reduce hemolysis in liver transplant patients with hepatitis C virus infection
    Ashok B Jain
    Transplantation Institute, The Department of Surgery, University of Pittsburgh, Pittsburgh, PA 15213, USA
    Liver Transpl 8:1007-13. 2002
    ..Further pharmacokinetic studies of ribavirin in LTx patients with varying degrees of renal function may allow the development of an algorithm for the safer use of ribavirin in HCV-positive LTx patients...
  30. ncbi request reprint A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C
    Ashok Jain
    Thomas E Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
    Liver Transpl 8:40-6. 2002
    ..In addition, there was no difference in HAI or fibrosis score between the two groups. Either MMF has no anti-HCV effect or its immunosuppressive properties overwhelm its antiviral effect in the clinical setting...
  31. ncbi request reprint Isolated renal allograft arterial mucormycosis: an extremely rare complication
    Mukut Minz
    Nephrol Dial Transplant 18:1034-5. 2003
  32. doi request reprint Common iliac artery lying posterior to psoas major identified during kidney transplantation
    Ashok Jain
    Transplantation 86:623-4. 2008
  33. ncbi request reprint Risk factors for late kidney allograft failure
    Navalkishor Udgiri
    Kidney Int 63:1960-1; author reply 1961. 2003